ABL Bio
About:
ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.
Website: https://www.ablbio.com/
Top Investors: IMM Investment, DSC Investment, Korea Investment Partners, DS Asset Management, Hana Financial Investment
Description:
ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Their core values are life-improvement, collaboration, innovation, and novel therapy.
Total Funding Amount:
$93.8M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Seongnam, Kyonggi-do, South Korea
Founded Date:
2016-01-01
Founders:
Sang Hoon Lee
Number of Employees:
51-100
Last Funding Date:
2023-09-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai